Cargando…
Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604510/ https://www.ncbi.nlm.nih.gov/pubmed/34666622 http://dx.doi.org/10.1080/22221751.2021.1996210 |
| _version_ | 1784601977234128896 |
|---|---|
| author | Yue, Lei Zhou, Jian Zhou, Yanan Yang, Xiaolei Xie, Tianhong Yang, Mengli Zhao, Hongling Zhao, Yuan Yang, Ting Li, Hua Xiang, Hong Wang, Jie Lu, Shuaiyao Liu, Hongqi Zhao, Hong Wei, Xingchen Zhang, Yuhao Xie, Zhongping |
| author_facet | Yue, Lei Zhou, Jian Zhou, Yanan Yang, Xiaolei Xie, Tianhong Yang, Mengli Zhao, Hongling Zhao, Yuan Yang, Ting Li, Hua Xiang, Hong Wang, Jie Lu, Shuaiyao Liu, Hongqi Zhao, Hong Wei, Xingchen Zhang, Yuhao Xie, Zhongping |
| author_sort | Yue, Lei |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8604510 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Taylor & Francis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86045102021-11-20 Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern Yue, Lei Zhou, Jian Zhou, Yanan Yang, Xiaolei Xie, Tianhong Yang, Mengli Zhao, Hongling Zhao, Yuan Yang, Ting Li, Hua Xiang, Hong Wang, Jie Lu, Shuaiyao Liu, Hongqi Zhao, Hong Wei, Xingchen Zhang, Yuhao Xie, Zhongping Emerg Microbes Infect Letter Taylor & Francis 2021-11-16 /pmc/articles/PMC8604510/ /pubmed/34666622 http://dx.doi.org/10.1080/22221751.2021.1996210 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Yue, Lei Zhou, Jian Zhou, Yanan Yang, Xiaolei Xie, Tianhong Yang, Mengli Zhao, Hongling Zhao, Yuan Yang, Ting Li, Hua Xiang, Hong Wang, Jie Lu, Shuaiyao Liu, Hongqi Zhao, Hong Wei, Xingchen Zhang, Yuhao Xie, Zhongping Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern |
| title | Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern |
| title_full | Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern |
| title_fullStr | Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern |
| title_full_unstemmed | Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern |
| title_short | Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern |
| title_sort | antibody response elicited by a third boost dose of inactivated sars-cov-2 vaccine can neutralize sars-cov-2 variants of concern |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604510/ https://www.ncbi.nlm.nih.gov/pubmed/34666622 http://dx.doi.org/10.1080/22221751.2021.1996210 |
| work_keys_str_mv | AT yuelei antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT zhoujian antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT zhouyanan antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT yangxiaolei antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT xietianhong antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT yangmengli antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT zhaohongling antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT zhaoyuan antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT yangting antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT lihua antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT xianghong antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT wangjie antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT lushuaiyao antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT liuhongqi antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT zhaohong antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT weixingchen antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT zhangyuhao antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern AT xiezhongping antibodyresponseelicitedbyathirdboostdoseofinactivatedsarscov2vaccinecanneutralizesarscov2variantsofconcern |